바이오 이미징 시장 : 기술, 최종사용자, 용도별 - 세계 예측(2025-2030년)

The Bio-imaging Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 10.15%, to USD 3.33 billion by 2030.

The bio-imaging market encompasses a wide range of technologies and methods used to visualize biological processes in living organisms, primarily for clinical and research purposes. It includes modalities such as MRI, CT, ultrasound, PET, and optical imaging, each with unique applications in disease diagnosis, drug development, and biotechnology research. The necessity of bio-imaging arises from its essential role in non-invasively tracing disease progress, enabling personalized medicine, and facilitating early detection of conditions such as cancer and neurological disorders. Its application spans from clinical diagnostics to life sciences research, where it aids in understanding cellular mechanisms, evaluating therapeutic efficacy, and conducting drug discovery. The end-use scope includes hospitals, diagnostic centers, research institutions, and pharmaceutical companies, which demand these technologies to improve patient outcomes and advance scientific understanding.

Market growth is driven by technological advancements, increasing demand for minimally invasive diagnostic procedures, and rising prevalence of chronic diseases. Opportunities lie in expanding applications of AI and machine learning to improve image analysis and diagnostic accuracy, alongside growing investments in R&D from biotech firms aiming at innovation in imaging technologies. However, challenges include high equipment costs, regulatory hurdles, and a scarcity of skilled professionals. To overcome these, partnerships between technology developers and healthcare providers to create cost-effective solutions could be vital. Moreover, leveraging cloud computing for data storage and analysis can augment system efficiencies and reduce costs.

Innovation can be spearheaded by integrating AI-based diagnostic tools and the development of portable imaging devices, enhancing accessibility in remote areas. The bio-imaging market exhibits dynamic growth, with increasing reliance on precision medicine and personalized treatment plans, making it crucial for stakeholders to adopt strategies that prioritize these advancements. Research into novel imaging agents that can provide more detailed contrast in molecular imaging could unlock further potential in the market. Thus, staying abreast of technological trends and efficient regulatory navigation is essential for businesses eager to capitalize on emerging opportunities in bio-imaging.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-imaging Market

The Bio-imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for early diagnosis of diseases with the rise in the aging population
  • Rise in the number of hospitals and diagnostic centers across the world
  • Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
• Market Restraints
  • Complexities in performing bio-imaging and the need for skilled personnel
• Market Opportunities
  • Technological innovations in bio-imaging technology to improve its functionality and performance
  • Adoption of bio-imaging solutions in personalized medicine
• Market Challenges
  • Concerns related to resolution, clarity, and processing time

Porter's Five Forces: A Strategic Tool for Navigating the Bio-imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-imaging Market

A detailed market share analysis in the Bio-imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-imaging Market

A strategic analysis of the Bio-imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT, Nanoco Group PLC, Perspectum Ltd., Positron Corporation, Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Bio-imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Optical Imaging, Positron Emission Tomography, Single-Photon Emission Computed Tomography, Ultrasound, and X-ray Imaging.
• Based on End-User, market is studied across Clinics, Diagnostic Centers, Hospitals, and Laboratories.
• Based on Application, market is studied across Agricultural Research, Clinical Diagnostics, Drug Discovery & Development, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for early diagnosis of diseases with the rise in the aging population
    • 5.1.1.2. Rise in the number of hospitals and diagnostic centers across the world
    • 5.1.1.3. Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in performing bio-imaging and the need for skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations in bio-imaging technology to improve its functionality and performance
    • 5.1.3.2. Adoption of bio-imaging solutions in personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to resolution, clarity, and processing time
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Emerging innovations to improve the efficiency and safety of x-ray imaging
  • 5.2.2. End-User: Expansion of hospitals across the world and provision of comprehensive healthcare solutions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

• 6.1. Introduction
• 6.2. Computed Tomography
• 6.3. Magnetic Resonance Imaging
• 6.4. Optical Imaging
• 6.5. Positron Emission Tomography
• 6.6. Single-Photon Emission Computed Tomography
• 6.7. Ultrasound
• 6.8. X-ray Imaging

7. Bio-imaging Market, by End-User

• 7.1. Introduction
• 7.2. Clinics
• 7.3. Diagnostic Centers
• 7.4. Hospitals
• 7.5. Laboratories

8. Bio-imaging Market, by Application

• 8.1. Introduction
• 8.2. Agricultural Research
• 8.3. Clinical Diagnostics
• 8.4. Drug Discovery & Development
• 8.5. Research Laboratories

9. Americas Bio-imaging Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bio-imaging Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bio-imaging Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
  • 12.3.2. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BaySpec, Inc.
• 2. Bracco S.p.A.
• 3. Bruker Corporation
• 4. Canon Medical Systems Corporation
• 5. Esaote S.p.A
• 6. Fujifilm Holdings Corporation
• 7. GE HealthCare Technologies, Inc.
• 8. iThera Medical GmbH
• 9. Kitware, Inc.
• 10. Koninklijke Philips N.V.
• 11. Lantheus Medical Imaging, Inc.
• 12. M Squared Lasers Ltd.
• 13. MARS Bioimaging Limited
• 14. Medtronic PLC
• 15. MobileODT
• 16. Nanoco Group PLC
• 17. Perspectum Ltd.
• 18. Positron Corporation
• 19. Quibim, S.L.
• 20. RadNet, Inc.
• 21. Rivanna Medical, Inc.
• 22. Samsung Medison Co., Ltd.
• 23. Siemens Healthineers AG